About The Doctor

Dr. Michael Kluger

Surgical Oncologist , Assistant Professor of Surgery

Dr. Michael D Kluger, a surgical oncologist, doesn't believe doctors should treat peritoneal mesothelioma like many of the other metastatic diseases. This disease has a uniqueness that must be treated for its uniqueness. Many times because of its rarity, doctors don't understand how to treat the cancers related to asbestos. This disease differs greatly than most of the other diseases said Dr. Kluger.

Get In Touch

Presbyterian Hospital Columbia University Medical Center

Background

Dr. Michael Kluger earned his medical degree from New York University School of Medicine. He completed his general surgery residency at NewYork-Presbyterian Hospital/Columbia University Medical Center and his surgical oncology fellowship at Henri Mondor Hospital in France.

Dr. Kluger currently practices as a surgical oncologist at New York-Presbyterian Hospital/Columbia University Medical Center. His special areas of interest include peritoneal mesothelioma, hyperthermic intraperitoneal chemotherapy (HIPEC), and cytoreduction.

Message of Hope

People with this disease today can live significantly longer when they receive the right treatment from the start.

Get in Touch

Hope Exists

Dr. Kluger asserts that patients with peritoneal mesothelioma now receive better medical care than ever before, thanks to treatment with cytoreductive surgery and HIPEC. People with this disease today can live significantly longer when they receive the right treatment from the start. For this reason, Dr. Kluger urges patients to seek care at a specialty center immediately to lower the chances of misdiagnosis and mismanagement.

When facing a diagnosis of malignant peritoneal mesothelioma, it is crucial to find the right treatment right away. Contact Dr. Michael Kluger today.

  • Share

Dr. Michael Kluger

Specialty

Surgical Oncologist

Contact

Article Sources

Page Contributors